Literature DB >> 25837821

Inherited genetic variants associated with occurrence of multiple primary melanoma.

David C Gibbs1, Irene Orlow2, Peter A Kanetsky3, Li Luo4, Anne Kricker5, Bruce K Armstrong5, Hoda Anton-Culver6, Stephen B Gruber7, Loraine D Marrett8, Richard P Gallagher9, Roberto Zanetti10, Stefano Rosso10, Terence Dwyer11, Ajay Sharma2, Emily La Pilla2, Lynn From12, Klaus J Busam2, Anne E Cust5, David W Ollila1, Colin B Begg2, Marianne Berwick4, Nancy E Thomas13.   

Abstract

Recent studies, including genome-wide association studies, have identified several putative low-penetrance susceptibility loci for melanoma. We sought to determine their generalizability to genetic predisposition for multiple primary melanoma in the international population-based Genes, Environment, and Melanoma (GEM) Study. GEM is a case-control study of 1,206 incident cases of multiple primary melanoma and 2,469 incident first primary melanoma participants as the control group. We investigated the odds of developing multiple primary melanoma for 47 SNPs from 21 distinct genetic regions previously reported to be associated with melanoma. ORs and 95% confidence intervals were determined using logistic regression models adjusted for baseline features (age, sex, age by sex interaction, and study center). We investigated univariable models and built multivariable models to assess independent effects of SNPs. Eleven SNPs in 6 gene neighborhoods (TERT/CLPTM1L, TYRP1, MTAP, TYR, NCOA6, and MX2) and a PARP1 haplotype were associated with multiple primary melanoma. In a multivariable model that included only the most statistically significant findings from univariable modeling and adjusted for pigmentary phenotype, back nevi, and baseline features, we found TERT/CLPTM1L rs401681 (P = 0.004), TYRP1 rs2733832 (P = 0.006), MTAP rs1335510 (P = 0.0005), TYR rs10830253 (P = 0.003), and MX2 rs45430 (P = 0.008) to be significantly associated with multiple primary melanoma, while NCOA6 rs4911442 approached significance (P = 0.06). The GEM Study provides additional evidence for the relevance of these genetic regions to melanoma risk and estimates the magnitude of the observed genetic effect on development of subsequent primary melanoma. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25837821      PMCID: PMC4452425          DOI: 10.1158/1055-9965.EPI-14-1426

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

1.  Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals.

Authors:  Dmitri V Zaykin; Peter H Westfall; S Stanley Young; Maha A Karnoub; Michael J Wagner; Margaret G Ehm
Journal:  Hum Hered       Date:  2002       Impact factor: 0.444

2.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

3.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

Review 5.  Melanoma genetics: recent findings take us beyond well-traveled pathways.

Authors:  Matthew H Law; Stuart Macgregor; Nicholas K Hayward
Journal:  J Invest Dermatol       Date:  2012-04-05       Impact factor: 8.551

6.  Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma.

Authors:  Anne-Sophie Jannot; Roubila Meziani; Guylene Bertrand; Benedicte Gérard; Vincent Descamps; Alain Archimbaud; Catherine Picard; Laurence Ollivaud; Nicole Basset-Seguin; Delphine Kerob; Guy Lanternier; Celeste Lebbe; P Saiag; Beatrice Crickx; Françoise Clerget-Darpoux; Bernard Grandchamp; Nadem Soufir
Journal:  Eur J Hum Genet       Date:  2005-08       Impact factor: 4.246

7.  Vitamin D receptor polymorphisms in patients with cutaneous melanoma.

Authors:  Irene Orlow; Pampa Roy; Anne S Reiner; Sarah Yoo; Himali Patel; Susan Paine; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Nancy E Thomas; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Richard P Gallagher; Terence Dwyer; Peter A Kanetsky; Klaus Busam; Lynn From; Colin B Begg; Marianne Berwick
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

8.  Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.

Authors:  Christopher I Amos; Li-E Wang; Jeffrey E Lee; Jeffrey E Gershenwald; Wei V Chen; Shenying Fang; Roman Kosoy; Mingfeng Zhang; Abrar A Qureshi; Selina Vattathil; Christopher W Schacherer; Julie M Gardner; Yuling Wang; D Tim Bishop; Jennifer H Barrett; Stuart MacGregor; Nicholas K Hayward; Nicholas G Martin; David L Duffy; Graham J Mann; Anne Cust; John Hopper; Kevin M Brown; Elizabeth A Grimm; Yaji Xu; Younghun Han; Kaiyan Jing; Caitlin McHugh; Cathy C Laurie; Kim F Doheny; Elizabeth W Pugh; Michael F Seldin; Jiali Han; Qingyi Wei
Journal:  Hum Mol Genet       Date:  2011-09-17       Impact factor: 6.150

9.  Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease.

Authors:  Weili Zhang; Yu Chen; Xiaomin Yang; Jingyao Fan; Xuenan Mi; Jizheng Wang; Channa Zhang; Frank B Hu; Rutai Hui
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.

Authors:  Maria Peña-Chilet; Maite Blanquer-Maceiras; Maider Ibarrola-Villava; Conrado Martinez-Cadenas; Manuel Martin-Gonzalez; Cristina Gomez-Fernandez; Matias Mayor; Juan Antonio Aviles; Ana Lluch; Gloria Ribas
Journal:  BMC Cancer       Date:  2013-03-27       Impact factor: 4.430

View more
  20 in total

1.  Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.

Authors:  D C Gibbs; S V Ward; I Orlow; G Cadby; P A Kanetsky; L Luo; K J Busam; A Kricker; B K Armstrong; A E Cust; H Anton-Culver; R P Gallagher; R Zanetti; S Rosso; L Sacchetto; D W Ollila; C B Begg; M Berwick; N E Thomas
Journal:  Br J Dermatol       Date:  2017-10-06       Impact factor: 9.302

2.  Separate Primary Melanomas of the Bulbar Conjunctiva and Eyelid Skin: Clinical Implications of Multiple Primary Melanomas.

Authors:  Frances A Jacinto; George H Fisher; Edgar M Espana; Ilya M Leyngold; Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2016-04-21

3.  CLPTM1L gene rs402710 (C > T) and rs401681 (C > T) polymorphisms associate with decreased cancer risk: a meta-analysis.

Authors:  Jianzhou Tang; Changming Hu; Hua Mei; Liang Peng; Hui Li
Journal:  Oncotarget       Date:  2017-11-01

Review 4.  Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling.

Authors:  Efthymia Soura; Philip J Eliades; Kristen Shannon; Alexander J Stratigos; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2016-03       Impact factor: 11.527

5.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

6.  Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Authors:  Steven Vernali; Weston T Waxweiler; Patrick M Dillon; Peter A Kanetsky; Irene Orlow; Li Luo; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

7.  Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.

Authors:  Audrey Mauguen; Emily C Zabor; Nancy E Thomas; Marianne Berwick; Venkatraman E Seshan; Colin B Begg
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

8.  Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Authors:  Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

9.  Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Authors:  Asbjørg Stray-Pedersen; Hanne Sørmo Sorte; Pubudu Samarakoon; Tomasz Gambin; Ivan K Chinn; Zeynep H Coban Akdemir; Hans Christian Erichsen; Lisa R Forbes; Shen Gu; Bo Yuan; Shalini N Jhangiani; Donna M Muzny; Olaug Kristin Rødningen; Ying Sheng; Sarah K Nicholas; Lenora M Noroski; Filiz O Seeborg; Carla M Davis; Debra L Canter; Emily M Mace; Timothy J Vece; Carl E Allen; Harshal A Abhyankar; Philip M Boone; Christine R Beck; Wojciech Wiszniewski; Børre Fevang; Pål Aukrust; Geir E Tjønnfjord; Tobias Gedde-Dahl; Henrik Hjorth-Hansen; Ingunn Dybedal; Ingvild Nordøy; Silje F Jørgensen; Tore G Abrahamsen; Torstein Øverland; Anne Grete Bechensteen; Vegard Skogen; Liv T N Osnes; Mari Ann Kulseth; Trine E Prescott; Cecilie F Rustad; Ketil R Heimdal; John W Belmont; Nicholas L Rider; Javier Chinen; Tram N Cao; Eric A Smith; Maria Soledad Caldirola; Liliana Bezrodnik; Saul Oswaldo Lugo Reyes; Francisco J Espinosa Rosales; Nina Denisse Guerrero-Cursaru; Luis Alberto Pedroza; Cecilia M Poli; Jose L Franco; Claudia M Trujillo Vargas; Juan Carlos Aldave Becerra; Nicola Wright; Thomas B Issekutz; Andrew C Issekutz; Jordan Abbott; Jason W Caldwell; Diana K Bayer; Alice Y Chan; Alessandro Aiuti; Caterina Cancrini; Eva Holmberg; Christina West; Magnus Burstedt; Ender Karaca; Gözde Yesil; Hasibe Artac; Yavuz Bayram; Mehmed Musa Atik; Mohammad K Eldomery; Mohammad S Ehlayel; Stephen Jolles; Berit Flatø; Alison A Bertuch; I Celine Hanson; Victor W Zhang; Lee-Jun Wong; Jianhong Hu; Magdalena Walkiewicz; Yaping Yang; Christine M Eng; Eric Boerwinkle; Richard A Gibbs; William T Shearer; Robert Lyle; Jordan S Orange; James R Lupski
Journal:  J Allergy Clin Immunol       Date:  2016-07-16       Impact factor: 10.793

10.  Genetic variation in the vitamin D related pathway and breast cancer risk in women of African ancestry in the root consortium.

Authors:  Shengfeng Wang; Dezheng Huo; Sonia Kupfer; Dereck Alleyne; Temidayo O Ogundiran; Oladosu Ojengbede; Wei Zheng; Katherine L Nathanson; Barbara Nemesure; Stefan Ambs; Olufunmilayo I Olopade; Yonglan Zheng
Journal:  Int J Cancer       Date:  2017-09-23       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.